Dr Matthew Raymond Monte, MD | |
3278 Mitchell Blvd, Moody Afb, GA 31699-7103 | |
(229) 257-2778 | |
Not Available |
Full Name | Dr Matthew Raymond Monte |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Aerospace Medicine |
Location | 3278 Mitchell Blvd, Moody Afb, Georgia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396373445 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083A0100X | Preventive Medicine - Aerospace Medicine | ME0151734 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Matthew Raymond Monte, MD 3278 Mitchell Blvd, Moody Afb, GA 31699-1500 Ph: (229) 257-2778 | Dr Matthew Raymond Monte, MD 3278 Mitchell Blvd, Moody Afb, GA 31699-7103 Ph: (229) 257-2778 |
News Archive
Researchers from the Alcoy campus of the Polytechnic University of Valencia (UPV) have collaborated to design a prevision and simulation model that makes it possible to improve the flow of patients and assistance quality at the Department of Health of Alcoy (Alicante) and to manage the crisis derived from the COVID-19 pandemic.
A doctor at Scripps Green Hospital this week became the first in California to use a new drug-coated balloon to treat peripheral artery disease in a patient since regulatory approval of the IN.PACT Admiral device in January by the Food and Drug Administration.
Today, patients with precancerous lesions, or early-stage breast cancer are usually diagnosed after a mammography screening. This method of detection can lead to false-positives and overtreatment, since mammography cannot determine whether pre-cancerous cells will actually turn into breast cancer. This may all change after Sidney Fu, M.D., professor of medicine at the George Washington School of Medicine and Health Sciences (SMHS), completes his study of early breast cancer detection using novel small RNA (microRNA or miRNA) biomarkers.
Colchicine, a drug that's used to treat gout, has the beneficial side effect of lowering the risk of heart attack in patients taking it. Conversely, taxol, a drug for treating cancer, has the opposite effect; raising the risk of heart failure.
A new study published this Thursday shows that overweight patients told by their doctors to go to Weight Watchers lose around twice as much weight as people receiving standard weight loss care over 12 months.
› Verified 3 days ago